Zealand Pharma A/S | ZEAL - Gewinn Vor Steuern

Aktienkurs
346.60
Täglich Wechseln
5.40 1.58%
Monatlich
20.14%
Jährlich
-18.62%
Q2 Prognose
324.96




Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Moderna USD -799M 612M 2025-12
Organon & Co USD -148M 391M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -343M 335.1M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zealand Pharma A/S -406.5M 39.77M 2025-12